Bhutta Mahmood F, Head Karen, Chong Lee Yee, Daw Jessica, Schilder Anne Gm, Brennan-Jones Christopher G
Department Global Health and Infection, Brighton & Sussex Medical School, Brighton, UK.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
Chronic suppurative otitis media (CSOM), sometimes referred to as chronic otitis media, is a chronic inflammation and often polymicrobial infection of the middle ear and mastoid cavity, characterised by ear discharge (otorrhoea) through a perforated tympanic membrane. The predominant symptoms of CSOM are ear discharge and hearing loss. Aural toileting describes processes for manually cleaning the ear, including dry mopping (with cotton wool or tissue paper), suction clearance (typically under a microscope), or irrigation (using manual or automated syringing). Aural toileting can be used alone or in addition to other treatments for CSOM, such as antibiotics or topical antiseptics. This is one of a suite of seven Cochrane reviews evaluating the effects of non-surgical interventions for CSOM. This is the first update of a Cochrane review published in 2020.
To assess the benefits and harms of aural toilet procedures for people with chronic suppurative otitis media.
We searched the Cochrane ENT Register, CENTRAL, Ovid MEDLINE, Ovid Embase, and five other databases. We also searched ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (ICTRP). The searches were run on 15 June 2022.
We included randomised controlled trials with at least a one-week follow-up involving adults or children who had chronic ear discharge of unknown cause or CSOM, where the ear discharge had continued for more than two weeks. We included any aural toileting method as the intervention, at any frequency, and for any duration. The main comparisons were aural toileting versus placebo or no intervention, and one aural toileting method versus another aural toileting method. Within each comparison, we separated studies into those in which both groups received other concomitant treatments (e.g. antiseptics or antibiotics) and those without concomitant treatments.
We used standard Cochrane methodology. Our primary outcomes were resolution of ear discharge or 'dry ear' (whether otoscopically confirmed or not), measured at one week to up to two weeks, two weeks to up to four weeks, and after four weeks; health-related quality of life using a validated instrument; and ear pain (otalgia) or discomfort or local irritation. Secondary outcomes were hearing, serious complications, and adverse events (dizziness/vertigo/balance problems, ear bleeding). We used GRADE to assess the certainty of the evidence for each outcome.
This update did not find any new studies. We included three studies with 431 participants (465 ears) reporting on two comparisons. Two studies included only children with CSOM in the community (351 participants) and the other study (80 participants) included children and adults with chronic ear discharge for at least six weeks. One study recruited participants from the Solomon Islands, who were considered a 'high-risk' Indigenous group. None of the included studies reported health-related quality of life, ear pain, or ear bleeding. 1. Daily aural toileting versus no treatment Two studies (351 children; 370 ears) compared daily dry mopping with no treatment. For resolution of ear discharge after four weeks, only one study reported the results per person. We are very uncertain whether there is a difference at 16 weeks (risk ratio (RR) 1.01, 95% confidence interval (CI) 0.60 to 1.72; 1 study, 217 participants; very low-certainty evidence). There were no results reported for the adverse events of dizziness, vertigo, or balance problems. Only one study reported serious complications, but it was not clear which group these participants were from, or whether the complications occurred pre- or post-treatment, and therefore the certainty of evidence was very low. One study reported hearing, but the results were presented by treatment outcome rather than by treatment group, so it was not possible to determine whether there was a difference between the two groups. 2. Daily aural toileting versus single aural toileting episode (both in addition to topical ciprofloxacin) One study (80 participants; 95 ears) compared daily aural toileting (suction) with administration of topical antibiotic (ciprofloxacin) ear drops in a clinic, to a single aural toileting (suction) episode followed by daily self-administered topical antibiotic drops, in participants of all ages. We are very uncertain if there is a difference in resolution of ear discharge at between one and up to two weeks (RR 1.09, 95% CI 0.91 to 1.30; 1 study, 80 participants; very low-certainty evidence). The results for resolution of ear discharge after four weeks were presented by ear, not person, and could not be adjusted to by person. The authors only reported qualitatively that there was no difference between the two groups in hearing results (very low-certainty evidence). One participant in the group with single aural toileting and self-administration of topical antibiotic ear drops reported the adverse event of dizziness, which the authors attributed to the use of cold topical ciprofloxacin. It is very uncertain whether there is a difference between the groups (RR 0.33, 95% CI 0.01 to 7.95; 1 study, 80 participants; very low-certainty evidence). There were no results reported for the other adverse events of vertigo or balance problems, or for serious complications.
AUTHORS' CONCLUSIONS: We are very uncertain whether treatment with aural toileting is effective in resolving ear discharge in people with CSOM when compared to no treatment, due to a lack of data and the poor quality of the available evidence. The evidence was considered very low-certainty as there were concerns over risk of bias, indirectness, imprecision, and suspected publication bias. We also remain uncertain about other outcomes, including adverse events, as these were not well reported. Similarly, we are very uncertain whether daily suction clearance, followed by antibiotic ear drops administered at a clinic, is better than a single episode of suction clearance followed by self-administration of topical antibiotic ear drops. Limitations of the review include lack of recency in data, and limited information on certain population groups or interventions.
慢性化脓性中耳炎(CSOM),有时也被称为慢性中耳炎,是中耳和乳突腔的慢性炎症,通常为多微生物感染,其特征是通过鼓膜穿孔出现耳漏(耳溢液)。CSOM的主要症状是耳漏和听力损失。耳部清洁是指手动清洁耳朵的过程,包括干擦(用棉球或纸巾)、吸引清除(通常在显微镜下)或冲洗(使用手动或自动注射器)。耳部清洁可单独使用,也可作为CSOM其他治疗方法(如抗生素或局部防腐剂)的辅助手段。这是七篇Cochrane系统评价之一,旨在评估CSOM非手术干预措施的效果。这是2020年发表的Cochrane系统评价的首次更新。
评估耳部清洁程序对慢性化脓性中耳炎患者的益处和危害。
我们检索了Cochrane耳鼻喉科注册库、CENTRAL、Ovid MEDLINE、Ovid Embase和其他五个数据库。我们还检索了ClinicalTrials.gov和世界卫生组织国际临床试验注册平台(ICTRP)。检索于2022年6月15日进行。
我们纳入了至少为期一周随访的随机对照试验,试验对象为患有不明原因慢性耳漏或CSOM的成人或儿童,耳漏持续时间超过两周。我们纳入任何耳部清洁方法作为干预措施,无论频率和持续时间如何。主要比较为耳部清洁与安慰剂或无干预,以及一种耳部清洁方法与另一种耳部清洁方法。在每个比较中,我们将研究分为两组均接受其他伴随治疗(如防腐剂或抗生素)的研究和未接受伴随治疗的研究。
我们采用标准的Cochrane方法。我们的主要结局指标为耳漏消失或“干耳”(无论是否经耳镜证实),分别在1周至2周、2周至4周以及4周后进行测量;使用经过验证的工具评估健康相关生活质量;以及耳痛(耳内疼痛)或不适或局部刺激。次要结局指标为听力、严重并发症和不良事件(头晕/眩晕/平衡问题、耳部出血)。我们使用GRADE评估每个结局指标证据的确定性。
本次更新未发现任何新的研究。我们纳入了三项研究,共431名参与者(465只耳朵),报告了两项比较。两项研究仅纳入社区中患有CSOM的儿童(351名参与者),另一项研究(80名参与者)纳入了慢性耳漏至少六周的儿童和成人。一项研究从所罗门群岛招募参与者,这些人被视为“高危”原住民群体。纳入的研究均未报告健康相关生活质量、耳痛或耳部出血情况。1. 每日耳部清洁与不治疗两项研究(351名儿童;370只耳朵)比较了每日干擦与不治疗的效果。对于四周后耳漏消失的情况,只有一项研究报告了每人的结果。我们非常不确定在16周时是否存在差异(风险比(RR)为1.01,95%置信区间(CI)为0.60至1.72;1项研究,217名参与者;极低确定性证据)。未报告头晕、眩晕或平衡问题等不良事件的结果。只有一项研究报告了严重并发症,但不清楚这些参与者来自哪一组,也不清楚并发症是在治疗前还是治疗后发生,因此证据的确定性非常低。一项研究报告了听力情况,但结果是按治疗结局而非治疗组呈现的,因此无法确定两组之间是否存在差异。2. 每日耳部清洁与单次耳部清洁(均联合外用环丙沙星)一项研究(80名参与者;95只耳朵)比较了每日耳部清洁(吸引)联合在诊所外用抗生素(环丙沙星)滴耳,与单次耳部清洁(吸引)后每日自行外用抗生素滴耳,纳入了所有年龄段的参与者。我们非常不确定在1周至2周之间耳漏消失情况是否存在差异(RR为1.09,95%CI为0.91至1.30;1项研究,80名参与者;极低确定性证据)。四周后耳漏消失的结果是按耳朵而非人报告的,无法按人进行调整。作者仅定性报告两组听力结果无差异(极低确定性证据)。单次耳部清洁并自行外用抗生素滴耳组有一名参与者报告了头晕的不良事件,作者将其归因于使用了冷的外用环丙沙星。两组之间是否存在差异非常不确定(RR为0.33,95%CI为0.01至7.95;1项研究,80名参与者;极低确定性证据)。未报告眩晕或平衡问题等其他不良事件以及严重并发症的结果。
由于缺乏数据且现有证据质量较差很难确定与不治疗相比,耳部清洁治疗对CSOM患者耳漏消失是否有效。由于存在偏倚风险、间接性、不精确性以及疑似发表偏倚等问题,证据被认为确定性非常低。我们对包括不良事件在内的其他结局也仍不确定,因为这些报告不佳。同样,我们也非常不确定每日吸引清除后在诊所使用抗生素滴耳是否优于单次吸引清除后自行外用抗生素滴耳。本系统评价的局限性包括数据缺乏时效性,以及关于某些人群组或干预措施的信息有限。